drugset / Trial / NCT02808052
Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency
Phase 1
Terminated
9 enrolled
Melinta Therapeutics, Inc.
Innovative Medicines Initiative · collabUniversitätsklinikum Köln · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, open-label, single-dose study of the safety, tolerability, and pharmacokinetics of Minocin® (minocycline) for injection in subjects with renal insufficiency.
Timeline
- Start
- 2017-05-29
- Primary completion
- 2018-06-04
- Completion
- 2018-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 200 mg | Intravenous |